52 results
DEF 14A
NTBL
Notable Labs Ltd
16 Feb 24
Definitive proxy
9:00am
expense allowance of $1,000 and reimbursement for ordinary and reasonable out-of-pocket business expenses incurred by him in furtherance of Notable’s … in effect from time to time. Additionally, the Wagner Agreement provides that Dr. Wagner is eligible to receive reimbursement for ordinary and reasonable out
PRE 14A
NTBL
Notable Labs Ltd
5 Feb 24
Preliminary proxy
5:00pm
with a monthly travel expense allowance of $1,000 and reimbursement for ordinary and reasonable out-of-pocket business expenses incurred by him … with Notable’s policies in effect from time to time. Additionally, the Wagner Agreement provides that Dr. Wagner is eligible to receive reimbursement
8-K
2dszkxg5rx10a2z
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
8-K
EX-10.4
t7fs 3nkfid0dqm
16 Oct 23
Notable Labs Closes Merger Transaction With VBL Therapeutics
4:05pm
424B3
hfmpwqecrc3yp8
5 Sep 23
Prospectus supplement
6:02pm
S-4/A
h39j2
30 Jun 23
Registration of securities issued in business combination transactions (amended)
4:38pm
10-Q
qrrf9jvy
15 May 23
Quarterly report
4:30pm
S-4
EX-10.11
bezlo58
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
w8ubnaqmhrkwvymv
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.14
7qnh06
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.9
iv538xez 37szo072d
11 May 23
Registration of securities issued in business combination transactions
9:09am
S-4
EX-10.15
8jrhc5n
11 May 23
Registration of securities issued in business combination transactions
9:09am